# ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis

> **NCT00379899** · PHASE4 · COMPLETED · sponsor: **Amgen** · enrollment: 360 (actual)

## Conditions studied

- Chronic Kidney Disease
- End Stage Renal Disease
- Coronary Artery Calcification
- Vascular Calcification
- Calcification
- Cardiovascular Disease
- Chronic Renal Failure
- Hyperparathyroidism
- Kidney Disease
- Nephrology
- Secondary Hyperparathyroidism

## Interventions

- **DRUG:** cinacalcet

## Key facts

- **NCT ID:** NCT00379899
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-05
- **Final completion:** 2009-11
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2014-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00379899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00379899, "ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00379899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*